Guest Contributor

Genome Canada head abruptly resigns

Guest Contributor
October 26, 2009

Dr Martin Godbout has resigned as president and CEO of Genome Canada after 10 years in the position, effective immediately. Godbout's departure was announced in a statement from Genome Canada board chair Dr Thomas Caskey, which said he was returning to the private sector "and pursue other opportunities in the genomics field".

... Please become a Member or login to read the rest of this article ...


Other stories mentioning these organizations, people and topics

Other News

University IP revenue declines 12% while research contract income soars to $1.2 billion

Canadian Stem Cell Foundation aims to raise level of awareness and activity for rapidly developing research field

Federal S&T outlays hit $10.7 billion but dip as percentage of federal spending

CIHR seeks 76% budget boost to realize long-standing target for health research






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.